Interventional Oncology Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Interventional oncology is a field of treatment that focuses on the treatment of cancers using minimally invasive procedures driven by image guidance. Interventional oncology is gaining a lot of popularity in the treatment of cancer because minimally invasive procedures are less painful and less risky than conventional operations. Market players develops products for interventional radiologists that specialize in treating patients with oncological indications. Rising to the challenge of creating innovative treatments for patients, market players bringing a complete range of interventional oncology products that focus on Access, Loco-regional treatments and Endovascular embolization.
MARKET DYNAMICS
Factors driving the growth of the interventional oncology device market are the growing Incidence rate of cancers worldwide, coupled with high preference for minimally invasive procedures. However, financial burden on the companies due to product recall is expected to hamper the growth of the market. Moreover, increasing funding from the government in the Developed Countries and favorable reimbursement scenario for interventional oncology treatment is anticipated to boost the market growth.
MARKET SCOPE
The "Interventional Oncology Device Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of interventional oncology device market with detailed market segmentation by product type, procedure, and cancer type. The interventional oncology device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in interventional oncology device market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The interventional oncology device market is segmented on the basis of product type, procedure, and cancer type. Based on product type, the market is segmented as ablation devices, embolization device, and support devices. Ablation devices sub segmented as microwave ablation, radiofrequency ablation, cryoablation, cryoablation, and others. Embolization device sub segmented as radioembolic agents and non-radioactive embolic agents. Support devices sub segmented as microcatheters and guidewires. On the basis of procedure, the market is categorized as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), transcatheter arterial embolization (TAE) or bland embolization. On the basis of cancer type, the market is categorized as lung cancer, breast cancer, liver cancer, kidney cancer, prostate cancer, and others
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the interventional oncology device market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The interventional oncology device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting interventional oncology device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the interventional oncology device market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the interventional oncology device market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The interventional oncology device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting interventional oncology device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the interventional oncology device market in these regions.
MARKET PLAYERS
The report covers key developments in the interventional oncology device market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from interventional oncology device market are anticipated to have lucrative growth opportunities in the future with the rising demand for interventional oncology device in the global market. Below mentioned is the list of few companies engaged in the interventional oncology device market.
The report also includes the profiles of key players in interventional oncology device market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boston Scientific Corporation
- Medtronic plc
- Merit Medical Systems Inc.
- Terumo Corporation
- HealthTronics Inc.
- Medtronic
- Sirtex Medical Limited
- AngioDynamics
- Johnson & Johnson Services, Inc.
- Teleflex Incorporated
- Cook
- Varian Medical Systems, Inc.
- Eckert & Ziegler BEBIG
- 3M
- MedWaves, Inc.
- IMBIOTECHNOLOGIES LTD.
- Trod Medical
- Smith Medical
- NEWTECH MEDICAL DEVICES
- IceCure Medical Ltd
- Accuray Incorporated
- Sanarus
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Interventional Oncology Device Market - By Product Type
1.3.2 Interventional Oncology Device Market - By Procedure
1.3.3 Interventional Oncology Device Market - By Cancer Type
1.3.4 Interventional Oncology Device Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTERVENTIONAL ONCOLOGY DEVICE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTERVENTIONAL ONCOLOGY DEVICE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTERVENTIONAL ONCOLOGY DEVICE MARKET - GLOBAL MARKET ANALYSIS
6.1. INTERVENTIONAL ONCOLOGY DEVICE - GLOBAL MARKET OVERVIEW
6.2. INTERVENTIONAL ONCOLOGY DEVICE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INTERVENTIONAL ONCOLOGY DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ABLATION DEVICES
7.3.1. Overview
7.3.2. Ablation Devices Market Forecast and Analysis
7.3.3. Microwave ablation Market
7.3.3.1. Overview
7.3.3.2. Microwave ablation Market Forecast and Analysis
7.3.4. Radiofrequency ablation Market
7.3.4.1. Overview
7.3.4.2. Radiofrequency ablation Market Forecast and Analysis
7.3.5. Cryoablation Market
7.3.5.1. Overview
7.3.5.2. Cryoablation Market Forecast and Analysis
7.3.6. Cryoablation Market
7.3.6.1. Overview
7.3.6.2. Cryoablation Market Forecast and Analysis
7.3.7. Others Market
7.3.7.1. Overview
7.3.7.2. Others Market Forecast and Analysis
7.4. EMBOLIZATION DEVICE
7.4.1. Overview
7.4.2. Embolization Device Market Forecast and Analysis
7.4.3. Radioembolic Agents Market
7.4.3.1. Overview
7.4.3.2. Radioembolic Agents Market Forecast and Analysis
7.4.4. Non-radioactive Embolic Agents Market
7.4.4.1. Overview
7.4.4.2. Non-radioactive Embolic Agents Market Forecast and Analysis
7.5. SUPPORT DEVICES
7.5.1. Overview
7.5.2. Support Devices Market Forecast and Analysis
7.5.3. Microcatheters Market
7.5.3.1. Overview
7.5.3.2. Microcatheters Market Forecast and Analysis
7.5.4. Guidewires Market
7.5.4.1. Overview
7.5.4.2. Guidewires Market Forecast and Analysis
8. INTERVENTIONAL ONCOLOGY DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - PROCEDURE
8.1. OVERVIEW
8.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
8.3. THERMAL TUMOR ABLATION
8.3.1. Overview
8.3.2. Thermal Tumor Ablation Market Forecast and Analysis
8.4. NON-THERMAL TUMOR ABLATION
8.4.1. Overview
8.4.2. Non-thermal Tumor Ablation Market Forecast and Analysis
8.5. TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE)
8.5.1. Overview
8.5.2. Transcatheter Arterial Chemoembolization (TACE) Market Forecast and Analysis
8.6. TRANSCATHETER ARTERIAL RADIOEMBOLIZATION (TARE) OR SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
8.6.1. Overview
8.6.2. Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT) Market Forecast and Analysis
8.7. TRANSCATHETER ARTERIAL EMBOLIZATION (TAE) OR BLAND EMBOLIZATION
8.7.1. Overview
8.7.2. Transcatheter Arterial Embolization (TAE) or Bland Embolization Market Forecast and Analysis
9. INTERVENTIONAL ONCOLOGY DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - CANCER TYPE
9.1. OVERVIEW
9.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
9.3. LUNG CANCER
9.3.1. Overview
9.3.2. Lung cancer Market Forecast and Analysis
9.4. BREAST CANCER
9.4.1. Overview
9.4.2. Breast Cancer Market Forecast and Analysis
9.5. LIVER CANCER
9.5.1. Overview
9.5.2. Liver Cancer Market Forecast and Analysis
9.6. KIDNEY CANCER
9.6.1. Overview
9.6.2. Kidney Cancer Market Forecast and Analysis
9.7. PROSTATE CANCER
9.7.1. Overview
9.7.2. Prostate Cancer Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. INTERVENTIONAL ONCOLOGY DEVICE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Interventional Oncology Device Market Overview
10.1.2 North America Interventional Oncology Device Market Forecasts and Analysis
10.1.3 North America Interventional Oncology Device Market Forecasts and Analysis - By Product Type
10.1.4 North America Interventional Oncology Device Market Forecasts and Analysis - By Procedure
10.1.5 North America Interventional Oncology Device Market Forecasts and Analysis - By Cancer Type
10.1.6 North America Interventional Oncology Device Market Forecasts and Analysis - By Countries
10.1.6.1 United States Interventional Oncology Device Market
10.1.6.1.1 United States Interventional Oncology Device Market by Product Type
10.1.6.1.2 United States Interventional Oncology Device Market by Procedure
10.1.6.1.3 United States Interventional Oncology Device Market by Cancer Type
10.1.6.2 Canada Interventional Oncology Device Market
10.1.6.2.1 Canada Interventional Oncology Device Market by Product Type
10.1.6.2.2 Canada Interventional Oncology Device Market by Procedure
10.1.6.2.3 Canada Interventional Oncology Device Market by Cancer Type
10.1.6.3 Mexico Interventional Oncology Device Market
10.1.6.3.1 Mexico Interventional Oncology Device Market by Product Type
10.1.6.3.2 Mexico Interventional Oncology Device Market by Procedure
10.1.6.3.3 Mexico Interventional Oncology Device Market by Cancer Type
10.2. EUROPE
10.2.1 Europe Interventional Oncology Device Market Overview
10.2.2 Europe Interventional Oncology Device Market Forecasts and Analysis
10.2.3 Europe Interventional Oncology Device Market Forecasts and Analysis - By Product Type
10.2.4 Europe Interventional Oncology Device Market Forecasts and Analysis - By Procedure
10.2.5 Europe Interventional Oncology Device Market Forecasts and Analysis - By Cancer Type
10.2.6 Europe Interventional Oncology Device Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Interventional Oncology Device Market
10.2.6.1.1 Germany Interventional Oncology Device Market by Product Type
10.2.6.1.2 Germany Interventional Oncology Device Market by Procedure
10.2.6.1.3 Germany Interventional Oncology Device Market by Cancer Type
10.2.6.2 France Interventional Oncology Device Market
10.2.6.2.1 France Interventional Oncology Device Market by Product Type
10.2.6.2.2 France Interventional Oncology Device Market by Procedure
10.2.6.2.3 France Interventional Oncology Device Market by Cancer Type
10.2.6.3 Italy Interventional Oncology Device Market
10.2.6.3.1 Italy Interventional Oncology Device Market by Product Type
10.2.6.3.2 Italy Interventional Oncology Device Market by Procedure
10.2.6.3.3 Italy Interventional Oncology Device Market by Cancer Type
10.2.6.4 Spain Interventional Oncology Device Market
10.2.6.4.1 Spain Interventional Oncology Device Market by Product Type
10.2.6.4.2 Spain Interventional Oncology Device Market by Procedure
10.2.6.4.3 Spain Interventional Oncology Device Market by Cancer Type
10.2.6.5 United Kingdom Interventional Oncology Device Market
10.2.6.5.1 United Kingdom Interventional Oncology Device Market by Product Type
10.2.6.5.2 United Kingdom Interventional Oncology Device Market by Procedure
10.2.6.5.3 United Kingdom Interventional Oncology Device Market by Cancer Type
10.2.6.6 Rest of Europe Interventional Oncology Device Market
10.2.6.6.1 Rest of Europe Interventional Oncology Device Market by Product Type
10.2.6.6.2 Rest of Europe Interventional Oncology Device Market by Procedure
10.2.6.6.3 Rest of Europe Interventional Oncology Device Market by Cancer Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Interventional Oncology Device Market Overview
10.3.2 Asia-Pacific Interventional Oncology Device Market Forecasts and Analysis
10.3.3 Asia-Pacific Interventional Oncology Device Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Interventional Oncology Device Market Forecasts and Analysis - By Procedure
10.3.5 Asia-Pacific Interventional Oncology Device Market Forecasts and Analysis - By Cancer Type
10.3.6 Asia-Pacific Interventional Oncology Device Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Interventional Oncology Device Market
10.3.6.1.1 Australia Interventional Oncology Device Market by Product Type
10.3.6.1.2 Australia Interventional Oncology Device Market by Procedure
10.3.6.1.3 Australia Interventional Oncology Device Market by Cancer Type
10.3.6.2 China Interventional Oncology Device Market
10.3.6.2.1 China Interventional Oncology Device Market by Product Type
10.3.6.2.2 China Interventional Oncology Device Market by Procedure
10.3.6.2.3 China Interventional Oncology Device Market by Cancer Type
10.3.6.3 India Interventional Oncology Device Market
10.3.6.3.1 India Interventional Oncology Device Market by Product Type
10.3.6.3.2 India Interventional Oncology Device Market by Procedure
10.3.6.3.3 India Interventional Oncology Device Market by Cancer Type
10.3.6.4 Japan Interventional Oncology Device Market
10.3.6.4.1 Japan Interventional Oncology Device Market by Product Type
10.3.6.4.2 Japan Interventional Oncology Device Market by Procedure
10.3.6.4.3 Japan Interventional Oncology Device Market by Cancer Type
10.3.6.5 South Korea Interventional Oncology Device Market
10.3.6.5.1 South Korea Interventional Oncology Device Market by Product Type
10.3.6.5.2 South Korea Interventional Oncology Device Market by Procedure
10.3.6.5.3 South Korea Interventional Oncology Device Market by Cancer Type
10.3.6.6 Rest of Asia-Pacific Interventional Oncology Device Market
10.3.6.6.1 Rest of Asia-Pacific Interventional Oncology Device Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Interventional Oncology Device Market by Procedure
10.3.6.6.3 Rest of Asia-Pacific Interventional Oncology Device Market by Cancer Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Interventional Oncology Device Market Overview
10.4.2 Middle East and Africa Interventional Oncology Device Market Forecasts and Analysis
10.4.3 Middle East and Africa Interventional Oncology Device Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Interventional Oncology Device Market Forecasts and Analysis - By Procedure
10.4.5 Middle East and Africa Interventional Oncology Device Market Forecasts and Analysis - By Cancer Type
10.4.6 Middle East and Africa Interventional Oncology Device Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Interventional Oncology Device Market
10.4.6.1.1 South Africa Interventional Oncology Device Market by Product Type
10.4.6.1.2 South Africa Interventional Oncology Device Market by Procedure
10.4.6.1.3 South Africa Interventional Oncology Device Market by Cancer Type
10.4.6.2 Saudi Arabia Interventional Oncology Device Market
10.4.6.2.1 Saudi Arabia Interventional Oncology Device Market by Product Type
10.4.6.2.2 Saudi Arabia Interventional Oncology Device Market by Procedure
10.4.6.2.3 Saudi Arabia Interventional Oncology Device Market by Cancer Type
10.4.6.3 U.A.E Interventional Oncology Device Market
10.4.6.3.1 U.A.E Interventional Oncology Device Market by Product Type
10.4.6.3.2 U.A.E Interventional Oncology Device Market by Procedure
10.4.6.3.3 U.A.E Interventional Oncology Device Market by Cancer Type
10.4.6.4 Rest of Middle East and Africa Interventional Oncology Device Market
10.4.6.4.1 Rest of Middle East and Africa Interventional Oncology Device Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Interventional Oncology Device Market by Procedure
10.4.6.4.3 Rest of Middle East and Africa Interventional Oncology Device Market by Cancer Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Interventional Oncology Device Market Overview
10.5.2 South and Central America Interventional Oncology Device Market Forecasts and Analysis
10.5.3 South and Central America Interventional Oncology Device Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Interventional Oncology Device Market Forecasts and Analysis - By Procedure
10.5.5 South and Central America Interventional Oncology Device Market Forecasts and Analysis - By Cancer Type
10.5.6 South and Central America Interventional Oncology Device Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Interventional Oncology Device Market
10.5.6.1.1 Brazil Interventional Oncology Device Market by Product Type
10.5.6.1.2 Brazil Interventional Oncology Device Market by Procedure
10.5.6.1.3 Brazil Interventional Oncology Device Market by Cancer Type
10.5.6.2 Argentina Interventional Oncology Device Market
10.5.6.2.1 Argentina Interventional Oncology Device Market by Product Type
10.5.6.2.2 Argentina Interventional Oncology Device Market by Procedure
10.5.6.2.3 Argentina Interventional Oncology Device Market by Cancer Type
10.5.6.3 Rest of South and Central America Interventional Oncology Device Market
10.5.6.3.1 Rest of South and Central America Interventional Oncology Device Market by Product Type
10.5.6.3.2 Rest of South and Central America Interventional Oncology Device Market by Procedure
10.5.6.3.3 Rest of South and Central America Interventional Oncology Device Market by Cancer Type
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INTERVENTIONAL ONCOLOGY DEVICE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INTERVENTIONAL ONCOLOGY DEVICE MARKET, KEY COMPANY PROFILES
13.1. BOSTON SCIENTIFIC CORPORATION
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MEDTRONIC PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MERIT MEDICAL SYSTEMS INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TERUMO CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. HEALTHTRONICS INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEDTRONIC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SIRTEX MEDICAL LIMITED
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ANGIODYNAMICS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. JOHNSON AND JOHNSON SERVICES, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TELEFLEX INCORPORATED
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. COOK
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
13.12. VARIAN MEDICAL SYSTEMS, INC.
13.12.1. Key Facts
13.12.2. Business Description
13.12.3. Products and Services
13.12.4. Financial Overview
13.12.5. SWOT Analysis
13.12.6. Key Developments
13.13. ECKERT AND ZIEGLER BEBIG
13.13.1. Key Facts
13.13.2. Business Description
13.13.3. Products and Services
13.13.4. Financial Overview
13.13.5. SWOT Analysis
13.13.6. Key Developments
13.14. 3M
13.14.1. Key Facts
13.14.2. Business Description
13.14.3. Products and Services
13.14.4. Financial Overview
13.14.5. SWOT Analysis
13.14.6. Key Developments
13.15. MEDWAVES, INC.
13.15.1. Key Facts
13.15.2. Business Description
13.15.3. Products and Services
13.15.4. Financial Overview
13.15.5. SWOT Analysis
13.15.6. Key Developments
13.16. IMBIOTECHNOLOGIES LTD.
13.16.1. Key Facts
13.16.2. Business Description
13.16.3. Products and Services
13.16.4. Financial Overview
13.16.5. SWOT Analysis
13.16.6. Key Developments
13.17. TROD MEDICAL
13.17.1. Key Facts
13.17.2. Business Description
13.17.3. Products and Services
13.17.4. Financial Overview
13.17.5. SWOT Analysis
13.17.6. Key Developments
13.18. SMITH MEDICAL
13.18.1. Key Facts
13.18.2. Business Description
13.18.3. Products and Services
13.18.4. Financial Overview
13.18.5. SWOT Analysis
13.18.6. Key Developments
13.19. NEWTECH MEDICAL DEVICES
13.19.1. Key Facts
13.19.2. Business Description
13.19.3. Products and Services
13.19.4. Financial Overview
13.19.5. SWOT Analysis
13.19.6. Key Developments
13.20. ICECURE MEDICAL LTD
13.20.1. Key Facts
13.20.2. Business Description
13.20.3. Products and Services
13.20.4. Financial Overview
13.20.5. SWOT Analysis
13.20.6. Key Developments
1. Boston Scientific Corporation
2. Medtronic plc
3. Merit Medical Systems Inc.
4. Terumo Corporation
5. HealthTronics Inc.
6. Medtronic
7. Sirtex Medical Limited
8. AngioDynamics
9. Johnson & Johnson Services, Inc.
10. Teleflex Incorporated
11. Cook
12. Varian Medical Systems, Inc.
13. Eckert & Ziegler BEBIG
14. 3M
15. MedWaves, Inc.
16. IMBIOTECHNOLOGIES LTD.
17. Trod Medical
18. Smith Medical
19. NEWTECH MEDICAL DEVICES
20. IceCure Medical Ltd
21. Accuray Incorporated
22. Sanarus
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For